Biomarkers in early-stage colorectal cancer: ready for prime time?
BACKGROUND/AIMS: During the last two decades, hundreds of reports have detailed putative prognostic and predictive biomarkers for colorectal cancer (CRC). However, the majority of these studies have been small and retrospective, reporting results that are highly likely to represent false positives....
المؤلفون الرئيسيون: | Church, D, Midgley, R, Kerr, D |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2012
|
مواد مشابهة
-
Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
حسب: Midgley, R, وآخرون
منشور في: (2005) -
The emergence of 'omics for the management of colorectal cancer.
حسب: Midgley, R, وآخرون
منشور في: (2011) -
Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
حسب: Midgley, R, وآخرون
منشور في: (2005) -
Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?
حسب: Joao Paulo Solar Vasconcelos, وآخرون
منشور في: (2022-12-01) -
Immunotherapy for colorectal cancer.
حسب: Midgley, R, وآخرون
منشور في: (2003)